Literature DB >> 25305282

Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes.

Ananda Basu1, Simmi Dube1, Sona Veettil1, Michael Slama1, Yogish C Kudva1, Thomas Peyser2, Rickey E Carter3, Claudio Cobelli4, Rita Basu5.   

Abstract

The premise of effective closed-loop insulin therapy for type 1 diabetes (T1D) relies on the accuracy of continuous interstitial fluid glucose sensing that represents the crucial afferent arm of such a system. An important determinant of sensor accuracy is the physiological time lag of glucose transport from the vascular to the interstitial space. The purpose of current studies was to determine the physiological time lag of glucose transport from the vascular to the abdominal subcutaneous interstitial space in T1D. Four microdialysis catheters were inserted into the abdominal subcutaneous space in 6 T1D subjects under overnight fasted conditions. Plasma glucose was maintained at 113.7 ± 6.3 mg/dl using a continuous intravenous insulin infusion. After sequential intravenous bolus administrations of glucose isotopes, timed plasma and interstitial fluid samples were collected chronologically and analyzed for tracer enrichments. We observed a median (range) time lag of tracer appearance (time to detection) into the interstitial space after intravenous bolus of 6.8 (4.8-9.8) minutes, with all participants having detectable values by 9.8 minutes. We conclude that in the overnight fasted state in T1D adults, the delay of glucose appearance from the vascular to the interstitial space is less than 10 minutes, thereby implying that this minimal physiological time lag should not be a major impediment to the development of an effective closed-loop control system for T1D.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  continuous glucose monitors; interstitial glucose concentration; microdialysis; subcutaneous glucose transport; type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25305282      PMCID: PMC4495531          DOI: 10.1177/1932296814554797

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  17 in total

1.  Frequency of lipodystrophy induced by recombinant human insulin.

Authors:  Z Hajheydari; Z Kashi; O Akha; S Akbarzadeh
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-10       Impact factor: 3.507

2.  Poor glycaemic control caused by insulin induced lipohypertrophy.

Authors:  Tahseen A Chowdhury; Valerie Escudier
Journal:  BMJ       Date:  2003-08-16

3.  Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.

Authors:  Kerstin Rebrin; Norman F Sheppard; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

4.  Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor.

Authors:  Apurv Kamath; Aarthi Mahalingam; James Brauker
Journal:  Diabetes Technol Ther       Date:  2009-11       Impact factor: 6.118

Review 5.  Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.

Authors:  Andreas Holstein; Helger Stege; Peter Kovacs
Journal:  Expert Opin Drug Saf       Date:  2010-03       Impact factor: 4.250

6.  Putative delays in interstitial fluid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself.

Authors:  Gayane Voskanyan; D Barry Keenan; John J Mastrototaro; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2007-09

7.  Determination of the 13C-labeling pattern of glucose by gas chromatography-mass spectrometry.

Authors:  M Beylot; S F Previs; F David; H Brunengraber
Journal:  Anal Biochem       Date:  1993-08-01       Impact factor: 3.365

8.  Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics.

Authors:  N H White; D Skor; J V Santiago
Journal:  Ann Intern Med       Date:  1982-08       Impact factor: 25.391

9.  Time lag of glucose from intravascular to interstitial compartment in humans.

Authors:  Ananda Basu; Simmi Dube; Michael Slama; Isabel Errazuriz; Jose Carlos Amezcua; Yogish C Kudva; Thomas Peyser; Rickey E Carter; Claudio Cobelli; Rita Basu
Journal:  Diabetes       Date:  2013-09-05       Impact factor: 9.461

10.  Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

Authors:  Ananda Basu; Chiara Dalla Man; Rita Basu; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

View more
  48 in total

1.  Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data.

Authors:  Michele Schiavon; Chiara Dalla Man; Simmi Dube; Michael Slama; Yogish C Kudva; Thomas Peyser; Ananda Basu; Rita Basu; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2015-08-27       Impact factor: 6.118

2.  Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.

Authors:  Lyvia Biagi; Arthur Hirata Bertachi; Ignacio Conget; Carmen Quirós; Marga Giménez; F Javier Ampudia-Blasco; Paolo Rossetti; Jorge Bondia; Josep Vehí
Journal:  J Diabetes Sci Technol       Date:  2017-06-21

3.  Accuracy of Continuous Glucose Monitoring in Patients After Total Pancreatectomy with Islet Autotransplantation.

Authors:  Gregory P Forlenza; Brandon M Nathan; Antoinette Moran; Ty B Dunn; Gregory J Beilman; Timothy L Pruett; Boris P Kovatchev; Melena D Bellin
Journal:  Diabetes Technol Ther       Date:  2016-04-22       Impact factor: 6.118

4.  The Accuracy of Continuous Glucose Monitoring and Flash Glucose Monitoring During Aerobic Exercise in Type 1 Diabetes.

Authors:  Dessi P Zaharieva; Michael C Riddell; Joseph Henske
Journal:  J Diabetes Sci Technol       Date:  2018-10-07

5.  Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings.

Authors:  Stefan Pleus; Michael Schoemaker; Karin Morgenstern; Günther Schmelzeisen-Redeker; Cornelia Haug; Manuela Link; Eva Zschornack; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2015-04-07

6.  Noninvasive glucose monitoring using mid-infrared absorption spectroscopy based on a few wavenumbers.

Authors:  Ryosuke Kasahara; Saiko Kino; Shunsuke Soyama; Yuji Matsuura
Journal:  Biomed Opt Express       Date:  2017-12-20       Impact factor: 3.732

Review 7.  Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes.

Authors:  Rozana Ramli; Monika Reddy; Nick Oliver
Journal:  Drugs       Date:  2019-07       Impact factor: 9.546

8.  Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.

Authors:  Dessi P Zaharieva; Kamuran Turksoy; Sarah M McGaugh; Rubin Pooni; Todd Vienneau; Trang Ly; Michael C Riddell
Journal:  Diabetes Technol Ther       Date:  2019-05-06       Impact factor: 6.118

9.  The Promise and Perils of Wearable Physiological Sensors for Diabetes Management.

Authors:  Frank L Schwartz; Cynthia R Marling; Razvan C Bunescu
Journal:  J Diabetes Sci Technol       Date:  2018-03-15

Review 10.  Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices.

Authors:  Guido Freckmann; Stefan Pleus; Mike Grady; Steven Setford; Brian Levy
Journal:  J Diabetes Sci Technol       Date:  2018-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.